Who
Kylie O'Keefe
Chief Customer & Strat Officer
Company insider
Files Form 4 as: Chief Customer & Strat Officer, uniQure.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $862K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Mar 2026
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $431K15,936 at $27.06 | filing |
| 11 Jun 2026filed 12 Jun 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $431K15,936 at $27.06 | filing |
| 4 Mar 2026filed 9 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Code A | —19,800 at $0.00 | filing |
| 4 Mar 2026filed 9 Mar 2026 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,900 at $0.00 | filing |
| 4 Mar 2026filed 9 Mar 2026 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,900 at $0.00 | filing |
| 4 Mar 2026filed 9 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Code A | —19,800 at $0.00 | filing |
News
Reviewing Alkermes (NASDAQ:ALKS) and uniQure (NASDAQ:QURE)QURE · tickerreport.com · 13 Oct 2026Vir Biotechnology (NASDAQ:VIR) vs. uniQure (NASDAQ:QURE) Critical ContrastQURE · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Kylie O'Keefe; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.